Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPRI 2: Cetuximab-based treatment in mCRC
NCT05312398Phase 2Active, not recruiting
- Sponsor
- University of Campania Luigi Vanvitelli
- Start
- Jul 2021
- Primary completion
- Aug 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in colorectal adenocarcinoma, sponsored by University of Campania Luigi Vanvitelli. Started Jul 2021; status: active, not recruiting.
02
Drugs
KL-140
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on NCT05312398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05312398.